27754271|t|SY 17-1 DYNAMIC REGULATION OF REDOX REGULATING FACTOR APE1 / REF-1 ON THE OXIDATIVE STRESS AND VASCULAR INFLAMMATION
27754271|a|Apurinic/apyrimidinic endonuclease 1 / redox factor-1 (APE1 / Ref-1) is a multifunctional protein that plays a central role in the cellular response to DNA damage and redox regulation against oxidative stress. APE1 / Ref-1 is essential for cellular survival and embryonic lethal in knockout mouse models. Heterozygous APE1 / Ref-1 mice showed impaired endothelium -dependent vasorelaxation, reduced vascular NO levels, and are hypertensive. APE1 / Ref-1 reduces intracellular reactive oxygen species production by negatively regulating the activity of the NADPH oxidase. APE1 / Ref-1 is predominantly localized in the nucleus; however, its subcellular localization is dynamically regulated. Recently, it was shown that APE1 / Ref-1 is secreted in response to hyperacetylation at specific lysine residues. We investigated the functions of extracellular APE1 / Ref-1 with respect to leading anti-inflammatory signaling in TNF-α -stimulated endothelial cells in response to acetylation. Trichostatin A (TSA), an inhibitor of histone deacetylase, considerably suppressed vascular cell adhesion molecule-1 (VCAM-1) in TNF-α -stimulated endothelial cells. During TSA -mediated acetylation in culture, a time - dependent increase in secreted APE1 / Ref-1 was confirmed. Recombinant human APE1 / Ref-1 with reducing activity induced a conformational change in TNFR1 by thiol-disulfide exchange. Following treatment with the neutralizing anti- APE1 / Ref-1 antibody, inflammatory signals via the binding of TNF-α to TNFR1 were remarkably recovered. Furthermore, rh APE1 / Ref-1 inhibited IL-1β - induced VCAM-1 expression in endothelial cells, and it inhibited iNOS or COX-2 expression in lipopolysaccharide -stimulated RAW 264.7 macrophage cells. These results strongly indicate that anti-inflammatory effects of secreted APE1 / Ref-1 and its property of secreted APE1 / Ref-1 may be useful as a therapeutic biomolecule in cardiovascular disease.
27754271	16	26	REGULATION	T038	UMLS:C1157519
27754271	30	35	REDOX	T038	UMLS:C0030012
27754271	36	58	REGULATING FACTOR APE1	T103	UMLS:C1451271
27754271	61	66	REF-1	T103	UMLS:C1451271
27754271	74	90	OXIDATIVE STRESS	T038	UMLS:C0242606
27754271	95	116	VASCULAR INFLAMMATION	T038	UMLS:C0947751
27754271	117	153	Apurinic/apyrimidinic endonuclease 1	T103	UMLS:C1451271
27754271	156	170	redox factor-1	T103	UMLS:C1451271
27754271	172	176	APE1	T103	UMLS:C1451271
27754271	179	184	Ref-1	T103	UMLS:C1451271
27754271	191	214	multifunctional protein	T103	UMLS:C0033684
27754271	248	279	cellular response to DNA damage	T038	UMLS:C1155291
27754271	284	300	redox regulation	T038	UMLS:C1655231
27754271	309	325	oxidative stress	T038	UMLS:C0242606
27754271	327	331	APE1	T103	UMLS:C1451271
27754271	334	339	Ref-1	T103	UMLS:C1451271
27754271	357	374	cellular survival	T038	UMLS:C0007620
27754271	379	395	embryonic lethal	T038	UMLS:C0752350
27754271	399	413	knockout mouse	T204	UMLS:C0206745
27754271	414	420	models	T204	UMLS:C0887965
27754271	435	439	APE1	T103	UMLS:C1451271
27754271	442	452	Ref-1 mice	T103	UMLS:C1451271
27754271	460	468	impaired	T037	UMLS:C0010957
27754271	469	480	endothelium	T017	UMLS:C0014257
27754271	492	506	vasorelaxation	T038	UMLS:C0042401
27754271	516	524	vascular	T017	UMLS:C0005847
27754271	525	534	NO levels	T058	UMLS:C3810607
27754271	544	556	hypertensive	T033	UMLS:C0857121
27754271	558	562	APE1	T103	UMLS:C1451271
27754271	565	570	Ref-1	T103	UMLS:C1451271
27754271	579	592	intracellular	T082	UMLS:C0178719
27754271	593	616	reactive oxygen species	T103	UMLS:C0162772
27754271	631	686	negatively regulating the activity of the NADPH oxidase	T038	UMLS:C1151146
27754271	688	692	APE1	T103	UMLS:C1451271
27754271	695	700	Ref-1	T103	UMLS:C1451271
27754271	718	727	localized	T082	UMLS:C0392752
27754271	735	742	nucleus	T017	UMLS:C0007610
27754271	757	768	subcellular	T017	UMLS:C0729605
27754271	785	806	dynamically regulated	T038	UMLS:C1327622
27754271	836	840	APE1	T103	UMLS:C1451271
27754271	843	848	Ref-1	T103	UMLS:C1451271
27754271	852	860	secreted	T038	UMLS:C1327616
27754271	864	892	response to hyperacetylation	T038	UMLS:C1521754
27754271	905	920	lysine residues	T103	UMLS:C0024337
27754271	942	951	functions	T038	UMLS:C1527118
27754271	955	968	extracellular	T017	UMLS:C0521119
27754271	969	973	APE1	T103	UMLS:C1451271
27754271	976	981	Ref-1	T103	UMLS:C1451271
27754271	1006	1033	anti-inflammatory signaling	T038	UMLS:C1148560
27754271	1037	1042	TNF-α	T103	UMLS:C1456820
27754271	1055	1072	endothelial cells	T017	UMLS:C0225336
27754271	1076	1084	response	T038	UMLS:C2612728
27754271	1088	1099	acetylation	T038	UMLS:C1521754
27754271	1101	1115	Trichostatin A	T103	UMLS:C0077063
27754271	1117	1120	TSA	T103	UMLS:C0077063
27754271	1126	1158	inhibitor of histone deacetylase	T103	UMLS:C1512474
27754271	1184	1217	vascular cell adhesion molecule-1	T103	UMLS:C0078056
27754271	1219	1225	VCAM-1	T103	UMLS:C0078056
27754271	1230	1235	TNF-α	T103	UMLS:C1456820
27754271	1248	1265	endothelial cells	T017	UMLS:C0225336
27754271	1274	1277	TSA	T103	UMLS:C0077063
27754271	1288	1299	acetylation	T038	UMLS:C1521754
27754271	1303	1310	culture	T058	UMLS:C0430400
27754271	1343	1351	secreted	T038	UMLS:C1327616
27754271	1352	1356	APE1	T103	UMLS:C1451271
27754271	1359	1364	Ref-1	T103	UMLS:C1451271
27754271	1369	1378	confirmed	T033	UMLS:C0750484
27754271	1380	1391	Recombinant	T103	UMLS:C0034861
27754271	1392	1402	human APE1	T103	UMLS:C0140145
27754271	1405	1410	Ref-1	T103	UMLS:C0140145
27754271	1444	1465	conformational change	T038	UMLS:C0301641
27754271	1469	1474	TNFR1	T103	UMLS:C0255808
27754271	1478	1502	thiol-disulfide exchange	T038	UMLS:C1151052
27754271	1514	1523	treatment	T058	UMLS:C0087111
27754271	1533	1545	neutralizing	T103	UMLS:C0475463
27754271	1552	1556	APE1	T103	UMLS:C1451271
27754271	1559	1564	Ref-1	T103	UMLS:C1451271
27754271	1565	1573	antibody	T103	UMLS:C0003241
27754271	1575	1595	inflammatory signals	T038	UMLS:C0037083
27754271	1604	1611	binding	T038	UMLS:C1167622
27754271	1615	1620	TNF-α	T103	UMLS:C1456820
27754271	1624	1629	TNFR1	T103	UMLS:C0255808
27754271	1670	1672	rh	T103	UMLS:C0034861
27754271	1673	1677	APE1	T103	UMLS:C1451271
27754271	1680	1685	Ref-1	T103	UMLS:C0140145
27754271	1696	1701	IL-1β	T103	UMLS:C0021753
27754271	1712	1718	VCAM-1	T103	UMLS:C0078056
27754271	1719	1729	expression	T038	UMLS:C1171362
27754271	1733	1750	endothelial cells	T017	UMLS:C0225336
27754271	1769	1773	iNOS	T103	UMLS:C1533698
27754271	1777	1782	COX-2	T103	UMLS:C0387583
27754271	1783	1793	expression	T038	UMLS:C1171362
27754271	1797	1815	lipopolysaccharide	T103	UMLS:C0023810
27754271	1828	1854	RAW 264.7 macrophage cells	T017	UMLS:C4042840
27754271	1922	1930	secreted	T038	UMLS:C1327616
27754271	1931	1935	APE1	T103	UMLS:C1451271
27754271	1938	1943	Ref-1	T103	UMLS:C1451271
27754271	1964	1972	secreted	T038	UMLS:C1327616
27754271	1973	1977	APE1	T103	UMLS:C1451271
27754271	1980	1985	Ref-1	T103	UMLS:C1451271
27754271	2032	2054	cardiovascular disease	T038	UMLS:C0007222